Whats bad about it, is the company with the exclusivity does not even have the product on the market yet!!! I don't understand how EGLT cant fight it. I think once the market can see that EGLT will sell their drug, the PPS will recover.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.